Hakan Alakus

6PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursLearning analytics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 24, 2023
Extension of resection after positive intraoperative pathology during surgery for gastric and gastroesophageal junction adenocarcinoma: a retrospective cohort study.

Patrick S Plum, Atakan G Barutcu, Aylin Pamuk

|Mar 29, 2023
Differentiated Thyroid Cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment

Costanza Chiapponi, Milan Janis Michael Hartmann, Boris Decarolis

|Jun 10, 2022
Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options.

Daniel Alexander Hescheler, Milan Janis Michael Hartmann, Burkhard Riemann

|Dec 24, 2021
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse.

Costanza Chiapponi, Milan J M Hartmann, Matthias Schmidt

|Jul 08, 2020
Y Chromosome Loss is a Frequent Event in Barrett's Adenocarcinoma and Associated with Poor Outcome.

Heike Loeser, Christina B Wölwer, Hakan Alakus

Pageof 1